CD38 and melanoma: The notion that CD38 targeting may serve as a potential therapeutic approach for patients with melanoma metastasis is supported by studies which showed that luteolin [43], apigenin and quercetin [29] (now known to be CD38 inhibitors [30, 31]) inhibited lung metastasis induced by intravenous injection of B16F10 cells to C57BL/6J mice.